HEALTH CATALYST INC (HCAT) Stock Balance Sheet
NASDAQ:HCAT - Nasdaq - US42225T1079 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 328.33M | 106.28M | 116.30M | 193.20M | 92.00M | |||
| Marketable Securities | 58.93M | 211.45M | 247.20M | 251.80M | 178.90M | |||
| Receivables | 51.65M | 60.29M | 48.00M | 48.80M | 48.30M | |||
| Other Current Assets | 18.51M | 15.38M | 16.30M | 14.60M | 10.60M | |||
| Total Current Assets | 457.41M | 393.40M | 427.80M | 508.40M | 329.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 39.13M | 39.64M | 42.60M | 44.40M | 37.60M | |||
| Goodwill | 234.39M | 190.65M | 186.00M | 170.00M | 107.80M | |||
| Intangibles | 76.46M | 73.38M | 92.20M | 104.80M | 98.90M | |||
| Other Non-Current Assets | 5.66M | 4.74M | 3.70M | 4.50M | 3.60M | |||
| Total Non-Current Assets | 355.64M | 308.42M | 324.50M | 323.70M | 247.90M | |||
| TOTAL ASSETS | 813.05M | 701.81M | 752.30M | 832.10M | 577.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 230.42M | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 26.88M | 26.64M | 23.10M | 27.20M | 19.10M | |||
| Accounts Payable | 14.28M | 6.64M | 4.40M | 4.70M | 5.30M | |||
| Other Current Liabilities | 52.20M | 55.75M | 55.00M | 61.20M | 63.60M | |||
| Total Current Liabilities | 323.78M | 89.03M | 82.50M | 93.10M | 88.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 114.61M | 228.03M | 226.50M | 180.90M | 169.00M | |||
| Other Non-Current Liabilities | 19.62M | 17.83M | 18.20M | 36.00M | 44.60M | |||
| Total Non-Current Liabilities | 134.23M | 245.86M | 244.80M | 216.90M | 213.60M | |||
| TOTAL LIABILITIES | 458.01M | 334.89M | 327.30M | 310.00M | 301.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.17B | -1.12B | -999.00M | -878.90M | -725.70M | |||
| Additional Paid In Capital | N/A | 1.48B | 1.42B | 1.40B | 1.00B | |||
| Common Shares | 1.52B | 58.00K | 100.00K | 100.00K | 0.00 | |||
| Other Shareholders' Equity | -110.00K | 33.00K | -600.00K | -100.00K | 100.00K | |||
| Shares Outstanding | 60.85M | 58.30M | 55.30M | 52.60M | 43.40M | |||
| Tangible Book Value per Share | 0.73 | 1.76 | 2.65 | 4.70 | 1.60 | |||
| Total Shareholders' Equity | 355.04M | 366.92M | 425.00M | 522.10M | 276.10M | |||
| TOTAL LIABILITIES AND EQUITY | 813.05M | 701.81M | 752.30M | 832.10M | 577.70M | |||
| Statistics | ||||||||
| Debt/Equity | 0.32 | 0.62 | 0.53 | 0.35 | 0.61 | |||
| Current Ratio | 1.41 | 4.42 | 5.19 | 5.46 | 3.75 | |||
| Return On Assets (ROA) | -9.73% | -16.83% | -18.26% | -18.41% | -19.91% | |||
| Return On Equity (ROE) | -22.29% | -32.20% | -32.33% | -29.34% | -41.65% | |||
All data in USD , ROIC based on taxRate of 0.21